Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONQUER-DVT colchicine after deep vein thrombosis trial
2025-521836-12-00Phase 2Authorised
- Sponsor
- Università degli Studi Gabriele d'Annunzio Chieti e Pescara
- Start
- Apr 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in deep vein thrombosis (DVT) comparing Colchicine with Placebo (2 arms). Primary endpoint: Post-thrombotic syndrome at 12 months. Planned start Apr 2026; status: authorised.
02
Drugs
colchicine
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2025-521836-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521836-12-00.